Skip to content

Serum Magnesium Level in Type 2 Diabetes Mellitus

Serum Magnesium Level in Type 2 Diabetes Mellitus

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06059833
Enrollment
120
Registered
2023-09-29
Start date
2023-09-30
Completion date
2024-09-30
Last updated
2023-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. It may be due to impaired insulin secretion, resistance to peripheral actions of insulin, or both . Chronic hyperglycemia in synergy with the other metabolic aberrations in patients with diabetes mellitus can cause damage to various organ systems, leading to the development of disabling and life-threatening health complications, most prominent of which are microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular complications leading to a 2-fold to 4-fold increased risk of cardiovascular diseases Mg2+ deficiency is usually identified by the measurement of serum Mg2+ concentration. Hypomagnesemia is defined by a serum Mg2+ concentration \< 0.75 mmol/L, but a deficiency due to low dietary intake in otherwise healthy people is uncommon. Although overt signs of clinical Mg2+ deficiency are not routinely recognized in the healthy population, relatively low Mg2+ intake and/or Mg2+ status have been shown to be associated with chronic diseases, including cardiovascular disease, T2DM, osteoporosis, pulmonary disease, depression, migraine headaches, inflammation, and cancer

Interventions

DIAGNOSTIC_TESTMagnesium

The aim of the study is to evaluate serum Mg level in type 2 DM patients.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to No maximum

Inclusion criteria

* • Type 2 Diabetes Mellitus according to WHO criteria.

Exclusion criteria

* • Renal failure patients. * Type I DM patients. * Acute pancreatitis. * Hyperthyroidism. * Hyperparathyroidism. * Malignancies. * Patients on loop/thiazide diuretics. * Patients on Mg supplement. * Patients on Mg containing antacids. * Any other conditions causing low Mg levels were excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
magnesium perecentage1 yearevaluate serum Mg level in type 2 DM patients.

Countries

Egypt

Contacts

Primary Contacthassnaa M kamel, resident
hasnaamohamed@med.sohage.edu.eg01009700227
Backup ContactElham o Hamd, professor
01063090309

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026